Spinal Stenosis: An Emerging Complication of Ageing in People With Haemophilia
- PMID: 40729454
- PMCID: PMC12462591
- DOI: 10.1111/hae.70089
Spinal Stenosis: An Emerging Complication of Ageing in People With Haemophilia
Abstract
Introduction: Advances in haemophilia care have brought the challenges of ageing for people with haemophilia (PWH) to the forefront. Age-related spinal degeneration may result in spinal stenosis; however, the rates in PWH are unknown. We sought to systematically review Irish PWH to address this gap in the current literature.
Methods: Clinical and radiological notes of all patients ≥40 years old (yo) registered with severe or moderate haemophilia A or B were reviewed, recording Haemophilia Joint Health Scores (HJHS), radiological imaging and orthopaedic/pain interventions.
Results: Of 100 males included with moderate or severe haemophilia, 13% had radiologically confirmed symptomatic spinal stenosis (reported rates 4% in the general population aged >60 yo). Persons with stenosis were older (median age 69yo vs. 55 yo, p = 0.004) with similar rates observed between those with moderate and severe haemophilia (4/35, 11.4% vs. 9/65, 13.8%). HJHS did not differ between those with and without stenosis (median 30 vs. 35, p = 0.6). On regression analysis, only age >60 yo was associated with an increased likelihood of spinal stenosis; severity of haemophilia (moderate vs. severe) was not significantly associated.
Conclusions: These data identify symptomatic spinal stenosis as a novel complication of ageing for PWH. Spinal stenosis rates were higher than expected for age in comparison to reported rates in the general population. Current joint assessments fail to capture spinal pathology, highlighting limitations of HJHS in older PWH. Increased awareness amongst PWH and health care providers of spinal stenosis is directly required; however, optimal management strategies for PWH with established stenosis are yet to be defined.
Keywords: ageing; arthropathy; haemophilia; spinal stenosis; spine; surgery.
© 2025 The Author(s). Haemophilia published by John Wiley & Sons Ltd.
Conflict of interest statement
C.K., J.M., A.M.H., C.B., A.O'G., K.R., M.O'D, K.S., J.S.B., S.D., M.K., have no COIs to declare. M.M. has received speaker fees from Sobi. N.L. has received speaker fees from Sobi. M.B. has served as a consultant for Sobi. N.M.O'C has received financial support for research from SOBI, consultancy fees from F. Hoffmann‐La Roche Ltd, UniQure, SOBI and CSL Behring, and is a member of the Speakers Bureau for F. Hoffmann‐La Roche Ltd, SOBI, CSL Behring, Takeda, Bayer and Novo Nordisk. All fees are donated to an institutional charitable body which supports education in Haemostasis and Thrombosis. P.L.T. is a full‐time employee of Baxalta Innovations GmbH, a member of the Takeda group of companies and shareholder of Takeda Pharmaceutical Company Limited. J.S.O'D has served on the speaker's bureau for Baxter, Bayer, Novo Nordisk, Sobi, Boehringer Ingelheim, Leo Pharma, Takeda and Octapharma. He has also served on the advisory boards of Baxter, Sobi, Bayer, Octapharma, CSL Behring, Daiichi Sankyo, Boehringer Ingelheim, Takeda and Pfizer. J.S.O.D has also received research grant funding awards from 3 M, Baxter, Bayer, Pfizer, Shire, Takeda, 3 M and Novo Nordisk. J.G. has received research funding from Takeda and Roche. M.L. has served on an advisory board for CSL Behring, as a consultant for Sobi, CSL Behring and Band Therapeutics, received speaker fees from Sobi and Takeda and research funding from Takeda
Figures
References
-
- Kennedy M., O' Mahony B., Roche S., et al., “Pain and Functional Disability Amongst Adults With Moderate and Severe Haemophilia From the Irish Personalised Approach to the Treatment of Haemophilia (iPATH) Study,” European Journal of Haematology 108 (2022): 518–527, 10.1111/ejh.13763. - DOI - PMC - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
